Antirotinib Hydrochloride
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Antirotinib Hydrochloride, covering 2024-10-16 to 2024-10-16. Get the full timeline:
Most recent: Clinical Trial Update: Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain Metastases [Phase 2]